nodes	percent_of_prediction	percent_of_DWPC	metapath
Metolazone—SLC12A3—respiratory system—lung cancer	0.00584	0.138	CbGeAlD
Metolazone—CA5B—mammary gland—lung cancer	0.00521	0.123	CbGeAlD
Metolazone—CA7—trachea—lung cancer	0.0044	0.104	CbGeAlD
Metolazone—CA12—respiratory system—lung cancer	0.00387	0.0916	CbGeAlD
Metolazone—SLC12A3—lung—lung cancer	0.0031	0.0734	CbGeAlD
Metolazone—CA12—trachea—lung cancer	0.00286	0.0677	CbGeAlD
Metolazone—CA5B—cardiac atrium—lung cancer	0.00241	0.0571	CbGeAlD
Metolazone—CA4—respiratory system—lung cancer	0.0024	0.0567	CbGeAlD
Metolazone—CA12—lung—lung cancer	0.00206	0.0487	CbGeAlD
Metolazone—CA5B—lung—lung cancer	0.00184	0.0437	CbGeAlD
Metolazone—CA4—trachea—lung cancer	0.00177	0.0419	CbGeAlD
Metolazone—CA4—cardiac atrium—lung cancer	0.00166	0.0394	CbGeAlD
Metolazone—CA4—bone marrow—lung cancer	0.0014	0.0333	CbGeAlD
Metolazone—CA4—lung—lung cancer	0.00127	0.0301	CbGeAlD
Metolazone—CA5B—lymph node—lung cancer	0.00126	0.0299	CbGeAlD
Metolazone—CA4—lymph node—lung cancer	0.00087	0.0206	CbGeAlD
Metolazone—Chest pain—Paclitaxel—lung cancer	0.000687	0.000819	CcSEcCtD
Metolazone—Arthralgia—Paclitaxel—lung cancer	0.000687	0.000819	CcSEcCtD
Metolazone—Anxiety—Paclitaxel—lung cancer	0.000685	0.000816	CcSEcCtD
Metolazone—Decreased appetite—Gemcitabine—lung cancer	0.000684	0.000815	CcSEcCtD
Metolazone—Nausea—Topotecan—lung cancer	0.00068	0.000811	CcSEcCtD
Metolazone—Discomfort—Paclitaxel—lung cancer	0.000679	0.000809	CcSEcCtD
Metolazone—Abdominal discomfort—Methotrexate—lung cancer	0.000679	0.000809	CcSEcCtD
Metolazone—Fatigue—Gemcitabine—lung cancer	0.000679	0.000808	CcSEcCtD
Metolazone—Pain—Gemcitabine—lung cancer	0.000673	0.000802	CcSEcCtD
Metolazone—Constipation—Gemcitabine—lung cancer	0.000673	0.000802	CcSEcCtD
Metolazone—Nausea—Erlotinib—lung cancer	0.000673	0.000802	CcSEcCtD
Metolazone—Dry mouth—Paclitaxel—lung cancer	0.000672	0.000801	CcSEcCtD
Metolazone—Diarrhoea—Vinorelbine—lung cancer	0.00067	0.000799	CcSEcCtD
Metolazone—Dysgeusia—Docetaxel—lung cancer	0.00067	0.000798	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000668	0.000796	CcSEcCtD
Metolazone—Feeling abnormal—Irinotecan—lung cancer	0.000666	0.000793	CcSEcCtD
Metolazone—Back pain—Docetaxel—lung cancer	0.000662	0.000789	CcSEcCtD
Metolazone—Gastrointestinal pain—Irinotecan—lung cancer	0.000661	0.000787	CcSEcCtD
Metolazone—Paraesthesia—Cisplatin—lung cancer	0.000659	0.000785	CcSEcCtD
Metolazone—Thrombocytopenia—Etoposide—lung cancer	0.000658	0.000784	CcSEcCtD
Metolazone—Muscle spasms—Docetaxel—lung cancer	0.000658	0.000784	CcSEcCtD
Metolazone—Erectile dysfunction—Methotrexate—lung cancer	0.000652	0.000777	CcSEcCtD
Metolazone—Dry skin—Doxorubicin—lung cancer	0.00065	0.000775	CcSEcCtD
Metolazone—Feeling abnormal—Gemcitabine—lung cancer	0.000649	0.000773	CcSEcCtD
Metolazone—Shock—Paclitaxel—lung cancer	0.000648	0.000772	CcSEcCtD
Metolazone—Dizziness—Vinorelbine—lung cancer	0.000648	0.000772	CcSEcCtD
Metolazone—Orthostatic hypotension—Doxorubicin—lung cancer	0.000648	0.000772	CcSEcCtD
Metolazone—Photosensitivity reaction—Methotrexate—lung cancer	0.000646	0.00077	CcSEcCtD
Metolazone—Hypokalaemia—Doxorubicin—lung cancer	0.000645	0.000769	CcSEcCtD
Metolazone—Thrombocytopenia—Paclitaxel—lung cancer	0.000645	0.000769	CcSEcCtD
Metolazone—Anorexia—Etoposide—lung cancer	0.000641	0.000763	CcSEcCtD
Metolazone—Abdominal pain—Irinotecan—lung cancer	0.000639	0.000761	CcSEcCtD
Metolazone—Toxic epidermal necrolysis—Doxorubicin—lung cancer	0.000639	0.000761	CcSEcCtD
Metolazone—Decreased appetite—Cisplatin—lung cancer	0.000638	0.00076	CcSEcCtD
Metolazone—Anaemia—Docetaxel—lung cancer	0.000633	0.000754	CcSEcCtD
Metolazone—Drowsiness—Methotrexate—lung cancer	0.000631	0.000752	CcSEcCtD
Metolazone—Anorexia—Paclitaxel—lung cancer	0.000628	0.000748	CcSEcCtD
Metolazone—Pain—Cisplatin—lung cancer	0.000627	0.000747	CcSEcCtD
Metolazone—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.000626	0.000746	CcSEcCtD
Metolazone—Vomiting—Vinorelbine—lung cancer	0.000623	0.000742	CcSEcCtD
Metolazone—Rash—Vinorelbine—lung cancer	0.000618	0.000736	CcSEcCtD
Metolazone—Dermatitis—Vinorelbine—lung cancer	0.000617	0.000735	CcSEcCtD
Metolazone—Abdominal distension—Doxorubicin—lung cancer	0.000617	0.000735	CcSEcCtD
Metolazone—Headache—Vinorelbine—lung cancer	0.000614	0.000731	CcSEcCtD
Metolazone—Syncope—Docetaxel—lung cancer	0.000614	0.000731	CcSEcCtD
Metolazone—Leukopenia—Docetaxel—lung cancer	0.000613	0.00073	CcSEcCtD
Metolazone—Palpitations—Docetaxel—lung cancer	0.000605	0.000721	CcSEcCtD
Metolazone—Feeling abnormal—Cisplatin—lung cancer	0.000605	0.00072	CcSEcCtD
Metolazone—Paraesthesia—Etoposide—lung cancer	0.000603	0.000719	CcSEcCtD
Metolazone—Loss of consciousness—Docetaxel—lung cancer	0.000601	0.000717	CcSEcCtD
Metolazone—Pancreatitis—Doxorubicin—lung cancer	0.000601	0.000716	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.0006	0.000715	CcSEcCtD
Metolazone—Somnolence—Etoposide—lung cancer	0.000597	0.000712	CcSEcCtD
Metolazone—Cough—Docetaxel—lung cancer	0.000597	0.000712	CcSEcCtD
Metolazone—Insomnia—Paclitaxel—lung cancer	0.000596	0.00071	CcSEcCtD
Metolazone—Epistaxis—Methotrexate—lung cancer	0.000595	0.000709	CcSEcCtD
Metolazone—Hypersensitivity—Irinotecan—lung cancer	0.000595	0.000709	CcSEcCtD
Metolazone—Paraesthesia—Paclitaxel—lung cancer	0.000592	0.000705	CcSEcCtD
Metolazone—Hypertension—Docetaxel—lung cancer	0.000591	0.000704	CcSEcCtD
Metolazone—Agranulocytosis—Methotrexate—lung cancer	0.000589	0.000702	CcSEcCtD
Metolazone—Somnolence—Paclitaxel—lung cancer	0.000586	0.000698	CcSEcCtD
Metolazone—Decreased appetite—Etoposide—lung cancer	0.000584	0.000696	CcSEcCtD
Metolazone—Chest pain—Docetaxel—lung cancer	0.000583	0.000694	CcSEcCtD
Metolazone—Arthralgia—Docetaxel—lung cancer	0.000583	0.000694	CcSEcCtD
Metolazone—Nausea—Vinorelbine—lung cancer	0.000582	0.000693	CcSEcCtD
Metolazone—Dyspepsia—Paclitaxel—lung cancer	0.00058	0.000691	CcSEcCtD
Metolazone—Asthenia—Irinotecan—lung cancer	0.00058	0.000691	CcSEcCtD
Metolazone—Fatigue—Etoposide—lung cancer	0.000579	0.00069	CcSEcCtD
Metolazone—Pain—Etoposide—lung cancer	0.000575	0.000685	CcSEcCtD
Metolazone—Constipation—Etoposide—lung cancer	0.000575	0.000685	CcSEcCtD
Metolazone—Decreased appetite—Paclitaxel—lung cancer	0.000573	0.000683	CcSEcCtD
Metolazone—Dry mouth—Docetaxel—lung cancer	0.00057	0.000679	CcSEcCtD
Metolazone—Fatigue—Paclitaxel—lung cancer	0.000568	0.000677	CcSEcCtD
Metolazone—Hepatitis—Methotrexate—lung cancer	0.000567	0.000675	CcSEcCtD
Metolazone—Asthenia—Gemcitabine—lung cancer	0.000565	0.000673	CcSEcCtD
Metolazone—Constipation—Paclitaxel—lung cancer	0.000563	0.000671	CcSEcCtD
Metolazone—Pain—Paclitaxel—lung cancer	0.000563	0.000671	CcSEcCtD
Metolazone—Photosensitivity reaction—Doxorubicin—lung cancer	0.00056	0.000667	CcSEcCtD
Metolazone—Pruritus—Gemcitabine—lung cancer	0.000557	0.000663	CcSEcCtD
Metolazone—Feeling abnormal—Etoposide—lung cancer	0.000554	0.00066	CcSEcCtD
Metolazone—Hyperglycaemia—Doxorubicin—lung cancer	0.000553	0.000659	CcSEcCtD
Metolazone—Diarrhoea—Irinotecan—lung cancer	0.000553	0.000659	CcSEcCtD
Metolazone—Gastrointestinal pain—Etoposide—lung cancer	0.00055	0.000655	CcSEcCtD
Metolazone—Shock—Docetaxel—lung cancer	0.000549	0.000655	CcSEcCtD
Metolazone—Thrombocytopenia—Docetaxel—lung cancer	0.000547	0.000652	CcSEcCtD
Metolazone—Drowsiness—Doxorubicin—lung cancer	0.000547	0.000651	CcSEcCtD
Metolazone—Feeling abnormal—Paclitaxel—lung cancer	0.000543	0.000647	CcSEcCtD
Metolazone—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000542	0.000646	CcSEcCtD
Metolazone—Hypersensitivity—Cisplatin—lung cancer	0.00054	0.000644	CcSEcCtD
Metolazone—Gastrointestinal pain—Paclitaxel—lung cancer	0.000539	0.000642	CcSEcCtD
Metolazone—Diarrhoea—Gemcitabine—lung cancer	0.000539	0.000642	CcSEcCtD
Metolazone—Erythema multiforme—Methotrexate—lung cancer	0.000536	0.000638	CcSEcCtD
Metolazone—Neuropathy peripheral—Doxorubicin—lung cancer	0.000536	0.000638	CcSEcCtD
Metolazone—Dizziness—Irinotecan—lung cancer	0.000534	0.000637	CcSEcCtD
Metolazone—Urticaria—Etoposide—lung cancer	0.000534	0.000636	CcSEcCtD
Metolazone—Anorexia—Docetaxel—lung cancer	0.000532	0.000634	CcSEcCtD
Metolazone—Abdominal pain—Etoposide—lung cancer	0.000531	0.000633	CcSEcCtD
Metolazone—Tinnitus—Methotrexate—lung cancer	0.000528	0.000629	CcSEcCtD
Metolazone—Asthenia—Cisplatin—lung cancer	0.000526	0.000627	CcSEcCtD
Metolazone—Urticaria—Paclitaxel—lung cancer	0.000523	0.000624	CcSEcCtD
Metolazone—Abdominal pain—Paclitaxel—lung cancer	0.000521	0.000621	CcSEcCtD
Metolazone—Epistaxis—Doxorubicin—lung cancer	0.000516	0.000614	CcSEcCtD
Metolazone—Vomiting—Irinotecan—lung cancer	0.000514	0.000612	CcSEcCtD
Metolazone—Agranulocytosis—Doxorubicin—lung cancer	0.00051	0.000608	CcSEcCtD
Metolazone—Rash—Irinotecan—lung cancer	0.000509	0.000607	CcSEcCtD
Metolazone—Dermatitis—Irinotecan—lung cancer	0.000509	0.000606	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000509	0.000606	CcSEcCtD
Metolazone—Chills—Methotrexate—lung cancer	0.000508	0.000606	CcSEcCtD
Metolazone—Headache—Irinotecan—lung cancer	0.000506	0.000603	CcSEcCtD
Metolazone—Insomnia—Docetaxel—lung cancer	0.000505	0.000602	CcSEcCtD
Metolazone—Diarrhoea—Cisplatin—lung cancer	0.000502	0.000598	CcSEcCtD
Metolazone—Paraesthesia—Docetaxel—lung cancer	0.000502	0.000598	CcSEcCtD
Metolazone—Vomiting—Gemcitabine—lung cancer	0.0005	0.000596	CcSEcCtD
Metolazone—Somnolence—Docetaxel—lung cancer	0.000497	0.000592	CcSEcCtD
Metolazone—Rash—Gemcitabine—lung cancer	0.000496	0.000591	CcSEcCtD
Metolazone—Dermatitis—Gemcitabine—lung cancer	0.000496	0.000591	CcSEcCtD
Metolazone—Hypersensitivity—Etoposide—lung cancer	0.000495	0.00059	CcSEcCtD
Metolazone—Headache—Gemcitabine—lung cancer	0.000493	0.000587	CcSEcCtD
Metolazone—Dyspepsia—Docetaxel—lung cancer	0.000492	0.000586	CcSEcCtD
Metolazone—Hepatitis—Doxorubicin—lung cancer	0.000491	0.000585	CcSEcCtD
Metolazone—Decreased appetite—Docetaxel—lung cancer	0.000486	0.000578	CcSEcCtD
Metolazone—Hypersensitivity—Paclitaxel—lung cancer	0.000485	0.000578	CcSEcCtD
Metolazone—Dysgeusia—Methotrexate—lung cancer	0.000483	0.000576	CcSEcCtD
Metolazone—Asthenia—Etoposide—lung cancer	0.000482	0.000575	CcSEcCtD
Metolazone—Fatigue—Docetaxel—lung cancer	0.000482	0.000574	CcSEcCtD
Metolazone—Nausea—Irinotecan—lung cancer	0.00048	0.000572	CcSEcCtD
Metolazone—Pain—Docetaxel—lung cancer	0.000478	0.000569	CcSEcCtD
Metolazone—Constipation—Docetaxel—lung cancer	0.000478	0.000569	CcSEcCtD
Metolazone—Back pain—Methotrexate—lung cancer	0.000477	0.000568	CcSEcCtD
Metolazone—Pruritus—Etoposide—lung cancer	0.000475	0.000567	CcSEcCtD
Metolazone—Asthenia—Paclitaxel—lung cancer	0.000473	0.000563	CcSEcCtD
Metolazone—Nausea—Gemcitabine—lung cancer	0.000467	0.000557	CcSEcCtD
Metolazone—Vomiting—Cisplatin—lung cancer	0.000466	0.000556	CcSEcCtD
Metolazone—Pruritus—Paclitaxel—lung cancer	0.000466	0.000555	CcSEcCtD
Metolazone—Vision blurred—Methotrexate—lung cancer	0.000465	0.000554	CcSEcCtD
Metolazone—Erythema multiforme—Doxorubicin—lung cancer	0.000464	0.000553	CcSEcCtD
Metolazone—Rash—Cisplatin—lung cancer	0.000463	0.000551	CcSEcCtD
Metolazone—Dermatitis—Cisplatin—lung cancer	0.000462	0.000551	CcSEcCtD
Metolazone—Feeling abnormal—Docetaxel—lung cancer	0.00046	0.000548	CcSEcCtD
Metolazone—Diarrhoea—Etoposide—lung cancer	0.00046	0.000548	CcSEcCtD
Metolazone—Ill-defined disorder—Methotrexate—lung cancer	0.000458	0.000545	CcSEcCtD
Metolazone—Tinnitus—Doxorubicin—lung cancer	0.000457	0.000545	CcSEcCtD
Metolazone—Gastrointestinal pain—Docetaxel—lung cancer	0.000457	0.000544	CcSEcCtD
Metolazone—Anaemia—Methotrexate—lung cancer	0.000456	0.000543	CcSEcCtD
Metolazone—Diarrhoea—Paclitaxel—lung cancer	0.000451	0.000537	CcSEcCtD
Metolazone—Malaise—Methotrexate—lung cancer	0.000445	0.00053	CcSEcCtD
Metolazone—Dizziness—Etoposide—lung cancer	0.000444	0.00053	CcSEcCtD
Metolazone—Vertigo—Methotrexate—lung cancer	0.000443	0.000528	CcSEcCtD
Metolazone—Abdominal pain—Docetaxel—lung cancer	0.000442	0.000526	CcSEcCtD
Metolazone—Leukopenia—Methotrexate—lung cancer	0.000442	0.000526	CcSEcCtD
Metolazone—Chills—Doxorubicin—lung cancer	0.00044	0.000525	CcSEcCtD
Metolazone—Dizziness—Paclitaxel—lung cancer	0.000436	0.000519	CcSEcCtD
Metolazone—Nausea—Cisplatin—lung cancer	0.000436	0.000519	CcSEcCtD
Metolazone—Cough—Methotrexate—lung cancer	0.00043	0.000513	CcSEcCtD
Metolazone—Vomiting—Etoposide—lung cancer	0.000427	0.000509	CcSEcCtD
Metolazone—Rash—Etoposide—lung cancer	0.000424	0.000505	CcSEcCtD
Metolazone—Dermatitis—Etoposide—lung cancer	0.000423	0.000504	CcSEcCtD
Metolazone—Headache—Etoposide—lung cancer	0.000421	0.000502	CcSEcCtD
Metolazone—Flatulence—Doxorubicin—lung cancer	0.000421	0.000501	CcSEcCtD
Metolazone—Arthralgia—Methotrexate—lung cancer	0.00042	0.0005	CcSEcCtD
Metolazone—Chest pain—Methotrexate—lung cancer	0.00042	0.0005	CcSEcCtD
Metolazone—Tension—Doxorubicin—lung cancer	0.000419	0.000499	CcSEcCtD
Metolazone—Vomiting—Paclitaxel—lung cancer	0.000419	0.000499	CcSEcCtD
Metolazone—Dysgeusia—Doxorubicin—lung cancer	0.000418	0.000498	CcSEcCtD
Metolazone—Rash—Paclitaxel—lung cancer	0.000415	0.000495	CcSEcCtD
Metolazone—Dermatitis—Paclitaxel—lung cancer	0.000415	0.000495	CcSEcCtD
Metolazone—Discomfort—Methotrexate—lung cancer	0.000415	0.000494	CcSEcCtD
Metolazone—Nervousness—Doxorubicin—lung cancer	0.000415	0.000494	CcSEcCtD
Metolazone—Back pain—Doxorubicin—lung cancer	0.000413	0.000492	CcSEcCtD
Metolazone—Headache—Paclitaxel—lung cancer	0.000413	0.000492	CcSEcCtD
Metolazone—Hypersensitivity—Docetaxel—lung cancer	0.000411	0.00049	CcSEcCtD
Metolazone—Muscle spasms—Doxorubicin—lung cancer	0.000411	0.000489	CcSEcCtD
Metolazone—Vision blurred—Doxorubicin—lung cancer	0.000403	0.00048	CcSEcCtD
Metolazone—Asthenia—Docetaxel—lung cancer	0.000401	0.000477	CcSEcCtD
Metolazone—Nausea—Etoposide—lung cancer	0.000399	0.000476	CcSEcCtD
Metolazone—Ill-defined disorder—Doxorubicin—lung cancer	0.000396	0.000472	CcSEcCtD
Metolazone—Pruritus—Docetaxel—lung cancer	0.000395	0.000471	CcSEcCtD
Metolazone—Anaemia—Doxorubicin—lung cancer	0.000395	0.00047	CcSEcCtD
Metolazone—Thrombocytopenia—Methotrexate—lung cancer	0.000394	0.00047	CcSEcCtD
Metolazone—Agitation—Doxorubicin—lung cancer	0.000392	0.000468	CcSEcCtD
Metolazone—Nausea—Paclitaxel—lung cancer	0.000391	0.000466	CcSEcCtD
Metolazone—Malaise—Doxorubicin—lung cancer	0.000385	0.000459	CcSEcCtD
Metolazone—Vertigo—Doxorubicin—lung cancer	0.000384	0.000457	CcSEcCtD
Metolazone—Anorexia—Methotrexate—lung cancer	0.000384	0.000457	CcSEcCtD
Metolazone—Syncope—Doxorubicin—lung cancer	0.000383	0.000456	CcSEcCtD
Metolazone—Leukopenia—Doxorubicin—lung cancer	0.000382	0.000456	CcSEcCtD
Metolazone—Diarrhoea—Docetaxel—lung cancer	0.000382	0.000455	CcSEcCtD
Metolazone—Palpitations—Doxorubicin—lung cancer	0.000377	0.00045	CcSEcCtD
Metolazone—Loss of consciousness—Doxorubicin—lung cancer	0.000375	0.000447	CcSEcCtD
Metolazone—Cough—Doxorubicin—lung cancer	0.000373	0.000444	CcSEcCtD
Metolazone—Dizziness—Docetaxel—lung cancer	0.000369	0.00044	CcSEcCtD
Metolazone—Hypertension—Doxorubicin—lung cancer	0.000369	0.000439	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000367	0.000437	CcSEcCtD
Metolazone—Insomnia—Methotrexate—lung cancer	0.000364	0.000434	CcSEcCtD
Metolazone—Chest pain—Doxorubicin—lung cancer	0.000364	0.000433	CcSEcCtD
Metolazone—Arthralgia—Doxorubicin—lung cancer	0.000364	0.000433	CcSEcCtD
Metolazone—Anxiety—Doxorubicin—lung cancer	0.000362	0.000432	CcSEcCtD
Metolazone—Paraesthesia—Methotrexate—lung cancer	0.000361	0.000431	CcSEcCtD
Metolazone—Discomfort—Doxorubicin—lung cancer	0.000359	0.000428	CcSEcCtD
Metolazone—Somnolence—Methotrexate—lung cancer	0.000358	0.000426	CcSEcCtD
Metolazone—Dry mouth—Doxorubicin—lung cancer	0.000356	0.000424	CcSEcCtD
Metolazone—Vomiting—Docetaxel—lung cancer	0.000355	0.000423	CcSEcCtD
Metolazone—Dyspepsia—Methotrexate—lung cancer	0.000354	0.000422	CcSEcCtD
Metolazone—Rash—Docetaxel—lung cancer	0.000352	0.00042	CcSEcCtD
Metolazone—Dermatitis—Docetaxel—lung cancer	0.000352	0.000419	CcSEcCtD
Metolazone—Decreased appetite—Methotrexate—lung cancer	0.00035	0.000417	CcSEcCtD
Metolazone—Headache—Docetaxel—lung cancer	0.00035	0.000417	CcSEcCtD
Metolazone—Fatigue—Methotrexate—lung cancer	0.000347	0.000414	CcSEcCtD
Metolazone—Pain—Methotrexate—lung cancer	0.000344	0.00041	CcSEcCtD
Metolazone—Shock—Doxorubicin—lung cancer	0.000343	0.000409	CcSEcCtD
Metolazone—Thrombocytopenia—Doxorubicin—lung cancer	0.000341	0.000407	CcSEcCtD
Metolazone—Anorexia—Doxorubicin—lung cancer	0.000332	0.000396	CcSEcCtD
Metolazone—Nausea—Docetaxel—lung cancer	0.000332	0.000395	CcSEcCtD
Metolazone—Feeling abnormal—Methotrexate—lung cancer	0.000332	0.000395	CcSEcCtD
Metolazone—Gastrointestinal pain—Methotrexate—lung cancer	0.000329	0.000392	CcSEcCtD
Metolazone—Urticaria—Methotrexate—lung cancer	0.00032	0.000381	CcSEcCtD
Metolazone—Abdominal pain—Methotrexate—lung cancer	0.000318	0.000379	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000318	0.000378	CcSEcCtD
Metolazone—Insomnia—Doxorubicin—lung cancer	0.000315	0.000376	CcSEcCtD
Metolazone—Paraesthesia—Doxorubicin—lung cancer	0.000313	0.000373	CcSEcCtD
Metolazone—Somnolence—Doxorubicin—lung cancer	0.00031	0.000369	CcSEcCtD
Metolazone—Dyspepsia—Doxorubicin—lung cancer	0.000307	0.000366	CcSEcCtD
Metolazone—Decreased appetite—Doxorubicin—lung cancer	0.000303	0.000361	CcSEcCtD
Metolazone—Fatigue—Doxorubicin—lung cancer	0.000301	0.000358	CcSEcCtD
Metolazone—Constipation—Doxorubicin—lung cancer	0.000298	0.000355	CcSEcCtD
Metolazone—Pain—Doxorubicin—lung cancer	0.000298	0.000355	CcSEcCtD
Metolazone—Hypersensitivity—Methotrexate—lung cancer	0.000297	0.000353	CcSEcCtD
Metolazone—Asthenia—Methotrexate—lung cancer	0.000289	0.000344	CcSEcCtD
Metolazone—Feeling abnormal—Doxorubicin—lung cancer	0.000287	0.000342	CcSEcCtD
Metolazone—Gastrointestinal pain—Doxorubicin—lung cancer	0.000285	0.00034	CcSEcCtD
Metolazone—Pruritus—Methotrexate—lung cancer	0.000285	0.000339	CcSEcCtD
Metolazone—Urticaria—Doxorubicin—lung cancer	0.000277	0.00033	CcSEcCtD
Metolazone—Abdominal pain—Doxorubicin—lung cancer	0.000276	0.000328	CcSEcCtD
Metolazone—Diarrhoea—Methotrexate—lung cancer	0.000275	0.000328	CcSEcCtD
Metolazone—Dizziness—Methotrexate—lung cancer	0.000266	0.000317	CcSEcCtD
Metolazone—Hypersensitivity—Doxorubicin—lung cancer	0.000257	0.000306	CcSEcCtD
Metolazone—Vomiting—Methotrexate—lung cancer	0.000256	0.000305	CcSEcCtD
Metolazone—Rash—Methotrexate—lung cancer	0.000254	0.000302	CcSEcCtD
Metolazone—Dermatitis—Methotrexate—lung cancer	0.000254	0.000302	CcSEcCtD
Metolazone—Headache—Methotrexate—lung cancer	0.000252	0.0003	CcSEcCtD
Metolazone—Asthenia—Doxorubicin—lung cancer	0.00025	0.000298	CcSEcCtD
Metolazone—Pruritus—Doxorubicin—lung cancer	0.000247	0.000294	CcSEcCtD
Metolazone—SLC12A3—Transmembrane transport of small molecules—ABCB1—lung cancer	0.000243	0.00205	CbGpPWpGaD
Metolazone—CA12—Metabolism—ABCC3—lung cancer	0.000242	0.00204	CbGpPWpGaD
Metolazone—CA9—Metabolism—CKB—lung cancer	0.000242	0.00204	CbGpPWpGaD
Metolazone—CA5A—Metabolism—ALDOA—lung cancer	0.000242	0.00204	CbGpPWpGaD
Metolazone—Nausea—Methotrexate—lung cancer	0.000239	0.000285	CcSEcCtD
Metolazone—Diarrhoea—Doxorubicin—lung cancer	0.000238	0.000284	CcSEcCtD
Metolazone—CA7—Metabolism—GNG11—lung cancer	0.000237	0.002	CbGpPWpGaD
Metolazone—CA5B—Metabolism—GNG11—lung cancer	0.000237	0.002	CbGpPWpGaD
Metolazone—CA5A—Metabolism—NCOA3—lung cancer	0.000235	0.00198	CbGpPWpGaD
Metolazone—CA12—Metabolism—AKR1C1—lung cancer	0.000234	0.00198	CbGpPWpGaD
Metolazone—Dizziness—Doxorubicin—lung cancer	0.000231	0.000275	CcSEcCtD
Metolazone—CA5A—Metabolism—ADCY1—lung cancer	0.000228	0.00193	CbGpPWpGaD
Metolazone—CA5A—Metabolism—ABCG2—lung cancer	0.000228	0.00193	CbGpPWpGaD
Metolazone—CA12—Metabolism—UGT1A1—lung cancer	0.000228	0.00192	CbGpPWpGaD
Metolazone—CA9—Metabolism—GSTM2—lung cancer	0.000228	0.00192	CbGpPWpGaD
Metolazone—CA9—Metabolism—CNDP2—lung cancer	0.000228	0.00192	CbGpPWpGaD
Metolazone—CA4—Metabolism—RRM1—lung cancer	0.000227	0.00192	CbGpPWpGaD
Metolazone—CA4—Metabolism—GSTA3—lung cancer	0.000227	0.00192	CbGpPWpGaD
Metolazone—CA5B—Metabolism—ALDOA—lung cancer	0.000226	0.0019	CbGpPWpGaD
Metolazone—CA7—Metabolism—ALDOA—lung cancer	0.000226	0.0019	CbGpPWpGaD
Metolazone—CA5A—Metabolism—HPGDS—lung cancer	0.000224	0.00189	CbGpPWpGaD
Metolazone—CA5A—Metabolism—ENO2—lung cancer	0.000224	0.00189	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PPP2R1B—lung cancer	0.000222	0.00188	CbGpPWpGaD
Metolazone—Vomiting—Doxorubicin—lung cancer	0.000222	0.000264	CcSEcCtD
Metolazone—CA9—Metabolism—MTMR3—lung cancer	0.000221	0.00187	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—CREBBP—lung cancer	0.00022	0.00186	CbGpPWpGaD
Metolazone—Rash—Doxorubicin—lung cancer	0.00022	0.000262	CcSEcCtD
Metolazone—Dermatitis—Doxorubicin—lung cancer	0.00022	0.000262	CcSEcCtD
Metolazone—CA12—Metabolism—GNG11—lung cancer	0.000219	0.00185	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—RB1—lung cancer	0.000219	0.00185	CbGpPWpGaD
Metolazone—CA7—Metabolism—NCOA3—lung cancer	0.000219	0.00185	CbGpPWpGaD
Metolazone—CA5B—Metabolism—NCOA3—lung cancer	0.000219	0.00185	CbGpPWpGaD
Metolazone—Headache—Doxorubicin—lung cancer	0.000218	0.00026	CcSEcCtD
Metolazone—CA5A—Metabolism—GSTT1—lung cancer	0.000217	0.00183	CbGpPWpGaD
Metolazone—CA9—Metabolism—PGAM1—lung cancer	0.000216	0.00182	CbGpPWpGaD
Metolazone—CA5A—Metabolism—GCLC—lung cancer	0.000214	0.00181	CbGpPWpGaD
Metolazone—CA5A—Metabolism—CYP2A6—lung cancer	0.000214	0.00181	CbGpPWpGaD
Metolazone—CA4—Metabolism—B4GALT5—lung cancer	0.000213	0.0018	CbGpPWpGaD
Metolazone—CA7—Metabolism—ADCY1—lung cancer	0.000213	0.0018	CbGpPWpGaD
Metolazone—CA7—Metabolism—ABCG2—lung cancer	0.000213	0.0018	CbGpPWpGaD
Metolazone—CA5B—Metabolism—ADCY1—lung cancer	0.000213	0.0018	CbGpPWpGaD
Metolazone—CA5B—Metabolism—ABCG2—lung cancer	0.000213	0.0018	CbGpPWpGaD
Metolazone—CA12—Metabolism—ALDOA—lung cancer	0.000209	0.00176	CbGpPWpGaD
Metolazone—CA7—Metabolism—ENO2—lung cancer	0.000209	0.00176	CbGpPWpGaD
Metolazone—CA5B—Metabolism—HPGDS—lung cancer	0.000209	0.00176	CbGpPWpGaD
Metolazone—CA7—Metabolism—HPGDS—lung cancer	0.000209	0.00176	CbGpPWpGaD
Metolazone—CA5B—Metabolism—ENO2—lung cancer	0.000209	0.00176	CbGpPWpGaD
Metolazone—CA4—Metabolism—GSTA4—lung cancer	0.000208	0.00175	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PPP2R1B—lung cancer	0.000208	0.00175	CbGpPWpGaD
Metolazone—CA7—Metabolism—PPP2R1B—lung cancer	0.000208	0.00175	CbGpPWpGaD
Metolazone—Nausea—Doxorubicin—lung cancer	0.000207	0.000247	CcSEcCtD
Metolazone—CA9—Metabolism—CYP2A7—lung cancer	0.000206	0.00174	CbGpPWpGaD
Metolazone—CA5A—Metabolism—ENO1—lung cancer	0.000203	0.00172	CbGpPWpGaD
Metolazone—CA12—Metabolism—NCOA3—lung cancer	0.000203	0.00171	CbGpPWpGaD
Metolazone—CA5B—Metabolism—GSTT1—lung cancer	0.000203	0.00171	CbGpPWpGaD
Metolazone—CA7—Metabolism—GSTT1—lung cancer	0.000203	0.00171	CbGpPWpGaD
Metolazone—CA4—Metabolism—GSTA2—lung cancer	0.000202	0.00171	CbGpPWpGaD
Metolazone—CA9—Metabolism—SDC4—lung cancer	0.000201	0.0017	CbGpPWpGaD
Metolazone—CA7—Metabolism—GCLC—lung cancer	0.0002	0.00169	CbGpPWpGaD
Metolazone—CA7—Metabolism—CYP2A6—lung cancer	0.0002	0.00169	CbGpPWpGaD
Metolazone—CA5B—Metabolism—GCLC—lung cancer	0.0002	0.00169	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CYP2A6—lung cancer	0.0002	0.00169	CbGpPWpGaD
Metolazone—CA12—Metabolism—ADCY1—lung cancer	0.000197	0.00167	CbGpPWpGaD
Metolazone—CA12—Metabolism—ABCG2—lung cancer	0.000197	0.00167	CbGpPWpGaD
Metolazone—CA4—Metabolism—GSTA1—lung cancer	0.000195	0.00165	CbGpPWpGaD
Metolazone—CA12—Metabolism—HPGDS—lung cancer	0.000193	0.00163	CbGpPWpGaD
Metolazone—CA12—Metabolism—ENO2—lung cancer	0.000193	0.00163	CbGpPWpGaD
Metolazone—CA4—Metabolism—ABCC3—lung cancer	0.000193	0.00163	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—CDKN2A—lung cancer	0.000193	0.00163	CbGpPWpGaD
Metolazone—CA12—Metabolism—PPP2R1B—lung cancer	0.000192	0.00162	CbGpPWpGaD
Metolazone—SLC12A3—Transmembrane transport of small molecules—APOA1—lung cancer	0.000192	0.00162	CbGpPWpGaD
Metolazone—CA5B—Metabolism—ENO1—lung cancer	0.00019	0.0016	CbGpPWpGaD
Metolazone—CA7—Metabolism—ENO1—lung cancer	0.00019	0.0016	CbGpPWpGaD
Metolazone—CA12—Metabolism—GSTT1—lung cancer	0.000188	0.00158	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—MDM2—lung cancer	0.000187	0.00158	CbGpPWpGaD
Metolazone—CA4—Metabolism—AKR1C1—lung cancer	0.000187	0.00158	CbGpPWpGaD
Metolazone—CA12—Metabolism—GCLC—lung cancer	0.000186	0.00157	CbGpPWpGaD
Metolazone—CA12—Metabolism—CYP2A6—lung cancer	0.000186	0.00157	CbGpPWpGaD
Metolazone—CA9—Metabolism—RRM1—lung cancer	0.000183	0.00155	CbGpPWpGaD
Metolazone—CA9—Metabolism—GSTA3—lung cancer	0.000183	0.00155	CbGpPWpGaD
Metolazone—CA5A—Metabolism—CYP2E1—lung cancer	0.000182	0.00154	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—MTOR—lung cancer	0.000182	0.00154	CbGpPWpGaD
Metolazone—CA4—Metabolism—UGT1A1—lung cancer	0.000181	0.00153	CbGpPWpGaD
Metolazone—CA5A—Metabolism—NQO1—lung cancer	0.00018	0.00152	CbGpPWpGaD
Metolazone—CA12—Metabolism—ENO1—lung cancer	0.000176	0.00148	CbGpPWpGaD
Metolazone—CA4—Metabolism—GNG11—lung cancer	0.000175	0.00148	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—CXCL8—lung cancer	0.000175	0.00148	CbGpPWpGaD
Metolazone—CA9—Metabolism—B4GALT5—lung cancer	0.000172	0.00146	CbGpPWpGaD
Metolazone—CA7—Metabolism—CYP2E1—lung cancer	0.00017	0.00144	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CYP2E1—lung cancer	0.00017	0.00144	CbGpPWpGaD
Metolazone—CA7—Metabolism—NQO1—lung cancer	0.000168	0.00142	CbGpPWpGaD
Metolazone—CA5B—Metabolism—NQO1—lung cancer	0.000168	0.00142	CbGpPWpGaD
Metolazone—CA9—Metabolism—GSTA4—lung cancer	0.000168	0.00142	CbGpPWpGaD
Metolazone—CA4—Metabolism—ALDOA—lung cancer	0.000167	0.00141	CbGpPWpGaD
Metolazone—CA9—Metabolism—GSTA2—lung cancer	0.000163	0.00138	CbGpPWpGaD
Metolazone—CA5A—Metabolism—STK11—lung cancer	0.000163	0.00137	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—JUN—lung cancer	0.000163	0.00137	CbGpPWpGaD
Metolazone—SLC12A3—Transmembrane transport of small molecules—CREBBP—lung cancer	0.000162	0.00137	CbGpPWpGaD
Metolazone—CA4—Metabolism—NCOA3—lung cancer	0.000162	0.00137	CbGpPWpGaD
Metolazone—CA12—Metabolism—CYP2E1—lung cancer	0.000158	0.00133	CbGpPWpGaD
Metolazone—CA9—Metabolism—GSTA1—lung cancer	0.000158	0.00133	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—CDKN1A—lung cancer	0.000158	0.00133	CbGpPWpGaD
Metolazone—CA4—Metabolism—ADCY1—lung cancer	0.000157	0.00133	CbGpPWpGaD
Metolazone—CA4—Metabolism—ABCG2—lung cancer	0.000157	0.00133	CbGpPWpGaD
Metolazone—CA9—Metabolism—ABCC3—lung cancer	0.000156	0.00132	CbGpPWpGaD
Metolazone—CA12—Metabolism—NQO1—lung cancer	0.000156	0.00132	CbGpPWpGaD
Metolazone—CA4—Metabolism—ENO2—lung cancer	0.000154	0.0013	CbGpPWpGaD
Metolazone—CA4—Metabolism—HPGDS—lung cancer	0.000154	0.0013	CbGpPWpGaD
Metolazone—CA4—Metabolism—PPP2R1B—lung cancer	0.000153	0.00129	CbGpPWpGaD
Metolazone—SLC12A3—Transmembrane transport of small molecules—ALB—lung cancer	0.000152	0.00128	CbGpPWpGaD
Metolazone—CA7—Metabolism—STK11—lung cancer	0.000152	0.00128	CbGpPWpGaD
Metolazone—CA5B—Metabolism—STK11—lung cancer	0.000152	0.00128	CbGpPWpGaD
Metolazone—CA9—Metabolism—AKR1C1—lung cancer	0.000151	0.00127	CbGpPWpGaD
Metolazone—CA5A—Metabolism—GSTP1—lung cancer	0.00015	0.00127	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—EP300—lung cancer	0.00015	0.00127	CbGpPWpGaD
Metolazone—CA4—Metabolism—GSTT1—lung cancer	0.00015	0.00126	CbGpPWpGaD
Metolazone—CA4—Metabolism—GCLC—lung cancer	0.000148	0.00125	CbGpPWpGaD
Metolazone—CA4—Metabolism—CYP2A6—lung cancer	0.000148	0.00125	CbGpPWpGaD
Metolazone—CA9—Metabolism—UGT1A1—lung cancer	0.000147	0.00124	CbGpPWpGaD
Metolazone—CA5A—Metabolism—CAT—lung cancer	0.000146	0.00124	CbGpPWpGaD
Metolazone—CA5A—Metabolism—ABCB1—lung cancer	0.000142	0.0012	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—VEGFA—lung cancer	0.000142	0.0012	CbGpPWpGaD
Metolazone—CA9—Metabolism—GNG11—lung cancer	0.000141	0.00119	CbGpPWpGaD
Metolazone—CA12—Metabolism—STK11—lung cancer	0.000141	0.00119	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—STAT3—lung cancer	0.000141	0.00119	CbGpPWpGaD
Metolazone—CA5B—Metabolism—GSTP1—lung cancer	0.00014	0.00119	CbGpPWpGaD
Metolazone—CA7—Metabolism—GSTP1—lung cancer	0.00014	0.00119	CbGpPWpGaD
Metolazone—CA4—Metabolism—ENO1—lung cancer	0.00014	0.00118	CbGpPWpGaD
Metolazone—CA5A—Metabolism—TYMS—lung cancer	0.00014	0.00118	CbGpPWpGaD
Metolazone—CA5A—Metabolism—GSTM1—lung cancer	0.000138	0.00117	CbGpPWpGaD
Metolazone—SLC12A3—Transmembrane transport of small molecules—RAF1—lung cancer	0.000137	0.00116	CbGpPWpGaD
Metolazone—CA7—Metabolism—CAT—lung cancer	0.000137	0.00115	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CAT—lung cancer	0.000137	0.00115	CbGpPWpGaD
Metolazone—CA9—Metabolism—ALDOA—lung cancer	0.000135	0.00114	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—MAPK3—lung cancer	0.000134	0.00113	CbGpPWpGaD
Metolazone—CA7—Metabolism—ABCB1—lung cancer	0.000133	0.00112	CbGpPWpGaD
Metolazone—CA5B—Metabolism—ABCB1—lung cancer	0.000133	0.00112	CbGpPWpGaD
Metolazone—CA5A—Metabolism—CYP1A1—lung cancer	0.000131	0.00111	CbGpPWpGaD
Metolazone—CA9—Metabolism—NCOA3—lung cancer	0.000131	0.0011	CbGpPWpGaD
Metolazone—CA5B—Metabolism—TYMS—lung cancer	0.000131	0.0011	CbGpPWpGaD
Metolazone—CA7—Metabolism—TYMS—lung cancer	0.000131	0.0011	CbGpPWpGaD
Metolazone—CA12—Metabolism—GSTP1—lung cancer	0.00013	0.0011	CbGpPWpGaD
Metolazone—CA5A—Metabolism—ERCC2—lung cancer	0.00013	0.0011	CbGpPWpGaD
Metolazone—CA7—Metabolism—GSTM1—lung cancer	0.000129	0.00109	CbGpPWpGaD
Metolazone—CA5B—Metabolism—GSTM1—lung cancer	0.000129	0.00109	CbGpPWpGaD
Metolazone—CA9—Metabolism—ADCY1—lung cancer	0.000127	0.00107	CbGpPWpGaD
Metolazone—CA9—Metabolism—ABCG2—lung cancer	0.000127	0.00107	CbGpPWpGaD
Metolazone—CA12—Metabolism—CAT—lung cancer	0.000127	0.00107	CbGpPWpGaD
Metolazone—CA4—Metabolism—CYP2E1—lung cancer	0.000126	0.00106	CbGpPWpGaD
Metolazone—CA9—Metabolism—HPGDS—lung cancer	0.000125	0.00105	CbGpPWpGaD
Metolazone—CA9—Metabolism—ENO2—lung cancer	0.000125	0.00105	CbGpPWpGaD
Metolazone—CA4—Metabolism—NQO1—lung cancer	0.000124	0.00105	CbGpPWpGaD
Metolazone—CA9—Metabolism—PPP2R1B—lung cancer	0.000124	0.00105	CbGpPWpGaD
Metolazone—CA12—Metabolism—ABCB1—lung cancer	0.000123	0.00104	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CYP1A1—lung cancer	0.000122	0.00103	CbGpPWpGaD
Metolazone—CA7—Metabolism—CYP1A1—lung cancer	0.000122	0.00103	CbGpPWpGaD
Metolazone—CA5B—Metabolism—ERCC2—lung cancer	0.000121	0.00102	CbGpPWpGaD
Metolazone—CA7—Metabolism—ERCC2—lung cancer	0.000121	0.00102	CbGpPWpGaD
Metolazone—CA12—Metabolism—TYMS—lung cancer	0.000121	0.00102	CbGpPWpGaD
Metolazone—CA9—Metabolism—GSTT1—lung cancer	0.000121	0.00102	CbGpPWpGaD
Metolazone—CA9—Metabolism—GCLC—lung cancer	0.00012	0.00101	CbGpPWpGaD
Metolazone—CA9—Metabolism—CYP2A6—lung cancer	0.00012	0.00101	CbGpPWpGaD
Metolazone—CA12—Metabolism—GSTM1—lung cancer	0.00012	0.00101	CbGpPWpGaD
Metolazone—CA9—Metabolism—ENO1—lung cancer	0.000113	0.000956	CbGpPWpGaD
Metolazone—CA12—Metabolism—CYP1A1—lung cancer	0.000113	0.000956	CbGpPWpGaD
Metolazone—CA5A—Metabolism—APOA1—lung cancer	0.000112	0.000949	CbGpPWpGaD
Metolazone—CA12—Metabolism—ERCC2—lung cancer	0.000112	0.000949	CbGpPWpGaD
Metolazone—CA4—Metabolism—STK11—lung cancer	0.000112	0.000946	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—TP53—lung cancer	0.000107	0.000905	CbGpPWpGaD
Metolazone—CA5B—Metabolism—APOA1—lung cancer	0.000105	0.000886	CbGpPWpGaD
Metolazone—CA7—Metabolism—APOA1—lung cancer	0.000105	0.000886	CbGpPWpGaD
Metolazone—CA4—Metabolism—GSTP1—lung cancer	0.000104	0.000876	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PIK3CG—lung cancer	0.000103	0.000866	CbGpPWpGaD
Metolazone—CA9—Metabolism—CYP2E1—lung cancer	0.000102	0.000858	CbGpPWpGaD
Metolazone—CA4—Metabolism—CAT—lung cancer	0.000101	0.000852	CbGpPWpGaD
Metolazone—CA9—Metabolism—NQO1—lung cancer	0.000101	0.000848	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—IL6—lung cancer	9.82e-05	0.000829	CbGpPWpGaD
Metolazone—CA4—Metabolism—ABCB1—lung cancer	9.82e-05	0.000829	CbGpPWpGaD
Metolazone—CA5A—Metabolism—POMC—lung cancer	9.77e-05	0.000825	CbGpPWpGaD
Metolazone—CA12—Metabolism—APOA1—lung cancer	9.72e-05	0.000821	CbGpPWpGaD
Metolazone—CA4—Metabolism—TYMS—lung cancer	9.64e-05	0.000814	CbGpPWpGaD
Metolazone—CA7—Metabolism—PIK3CG—lung cancer	9.58e-05	0.000809	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PIK3CG—lung cancer	9.58e-05	0.000809	CbGpPWpGaD
Metolazone—CA4—Metabolism—GSTM1—lung cancer	9.53e-05	0.000805	CbGpPWpGaD
Metolazone—CA5A—Metabolism—CREBBP—lung cancer	9.52e-05	0.000803	CbGpPWpGaD
Metolazone—CA5B—Metabolism—POMC—lung cancer	9.12e-05	0.00077	CbGpPWpGaD
Metolazone—CA7—Metabolism—POMC—lung cancer	9.12e-05	0.00077	CbGpPWpGaD
Metolazone—CA9—Metabolism—STK11—lung cancer	9.06e-05	0.000765	CbGpPWpGaD
Metolazone—CA4—Metabolism—CYP1A1—lung cancer	9.04e-05	0.000763	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PIK3CD—lung cancer	9.02e-05	0.000762	CbGpPWpGaD
Metolazone—CA4—Metabolism—ERCC2—lung cancer	8.96e-05	0.000756	CbGpPWpGaD
Metolazone—CA5A—Metabolism—ALB—lung cancer	8.91e-05	0.000752	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CREBBP—lung cancer	8.88e-05	0.00075	CbGpPWpGaD
Metolazone—CA7—Metabolism—CREBBP—lung cancer	8.88e-05	0.00075	CbGpPWpGaD
Metolazone—CA12—Metabolism—PIK3CG—lung cancer	8.88e-05	0.000749	CbGpPWpGaD
Metolazone—CA12—Metabolism—POMC—lung cancer	8.45e-05	0.000713	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PIK3CD—lung cancer	8.42e-05	0.000711	CbGpPWpGaD
Metolazone—CA7—Metabolism—PIK3CD—lung cancer	8.42e-05	0.000711	CbGpPWpGaD
Metolazone—CA9—Metabolism—GSTP1—lung cancer	8.38e-05	0.000708	CbGpPWpGaD
Metolazone—CA7—Metabolism—ALB—lung cancer	8.32e-05	0.000702	CbGpPWpGaD
Metolazone—CA5B—Metabolism—ALB—lung cancer	8.32e-05	0.000702	CbGpPWpGaD
Metolazone—CA12—Metabolism—CREBBP—lung cancer	8.23e-05	0.000695	CbGpPWpGaD
Metolazone—CA9—Metabolism—CAT—lung cancer	8.16e-05	0.000688	CbGpPWpGaD
Metolazone—CA9—Metabolism—ABCB1—lung cancer	7.94e-05	0.00067	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PIK3CB—lung cancer	7.86e-05	0.000664	CbGpPWpGaD
Metolazone—CA12—Metabolism—PIK3CD—lung cancer	7.8e-05	0.000659	CbGpPWpGaD
Metolazone—CA9—Metabolism—TYMS—lung cancer	7.79e-05	0.000658	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PTGS2—lung cancer	7.79e-05	0.000658	CbGpPWpGaD
Metolazone—CA4—Metabolism—APOA1—lung cancer	7.75e-05	0.000654	CbGpPWpGaD
Metolazone—CA12—Metabolism—ALB—lung cancer	7.7e-05	0.00065	CbGpPWpGaD
Metolazone—CA9—Metabolism—GSTM1—lung cancer	7.7e-05	0.00065	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PIK3CB—lung cancer	7.34e-05	0.00062	CbGpPWpGaD
Metolazone—CA7—Metabolism—PIK3CB—lung cancer	7.34e-05	0.00062	CbGpPWpGaD
Metolazone—CA9—Metabolism—CYP1A1—lung cancer	7.3e-05	0.000616	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PTGS2—lung cancer	7.27e-05	0.000614	CbGpPWpGaD
Metolazone—CA7—Metabolism—PTGS2—lung cancer	7.27e-05	0.000614	CbGpPWpGaD
Metolazone—CA9—Metabolism—ERCC2—lung cancer	7.24e-05	0.000611	CbGpPWpGaD
Metolazone—CA4—Metabolism—PIK3CG—lung cancer	7.08e-05	0.000597	CbGpPWpGaD
Metolazone—CA12—Metabolism—PIK3CB—lung cancer	6.8e-05	0.000574	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PTEN—lung cancer	6.8e-05	0.000574	CbGpPWpGaD
Metolazone—CA12—Metabolism—PTGS2—lung cancer	6.74e-05	0.000569	CbGpPWpGaD
Metolazone—CA4—Metabolism—POMC—lung cancer	6.74e-05	0.000569	CbGpPWpGaD
Metolazone—CA4—Metabolism—CREBBP—lung cancer	6.56e-05	0.000554	CbGpPWpGaD
Metolazone—CA5A—Metabolism—EP300—lung cancer	6.48e-05	0.000547	CbGpPWpGaD
Metolazone—CA7—Metabolism—PTEN—lung cancer	6.34e-05	0.000535	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PTEN—lung cancer	6.34e-05	0.000535	CbGpPWpGaD
Metolazone—CA9—Metabolism—APOA1—lung cancer	6.27e-05	0.000529	CbGpPWpGaD
Metolazone—CA4—Metabolism—PIK3CD—lung cancer	6.22e-05	0.000525	CbGpPWpGaD
Metolazone—CA4—Metabolism—ALB—lung cancer	6.14e-05	0.000518	CbGpPWpGaD
Metolazone—CA7—Metabolism—EP300—lung cancer	6.05e-05	0.000511	CbGpPWpGaD
Metolazone—CA5B—Metabolism—EP300—lung cancer	6.05e-05	0.000511	CbGpPWpGaD
Metolazone—CA12—Metabolism—PTEN—lung cancer	5.88e-05	0.000496	CbGpPWpGaD
Metolazone—CA9—Metabolism—PIK3CG—lung cancer	5.72e-05	0.000483	CbGpPWpGaD
Metolazone—CA12—Metabolism—EP300—lung cancer	5.61e-05	0.000473	CbGpPWpGaD
Metolazone—CA9—Metabolism—POMC—lung cancer	5.44e-05	0.00046	CbGpPWpGaD
Metolazone—CA4—Metabolism—PIK3CB—lung cancer	5.42e-05	0.000458	CbGpPWpGaD
Metolazone—CA4—Metabolism—PTGS2—lung cancer	5.37e-05	0.000454	CbGpPWpGaD
Metolazone—CA9—Metabolism—CREBBP—lung cancer	5.3e-05	0.000448	CbGpPWpGaD
Metolazone—CA9—Metabolism—PIK3CD—lung cancer	5.03e-05	0.000424	CbGpPWpGaD
Metolazone—CA9—Metabolism—ALB—lung cancer	4.96e-05	0.000419	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PIK3CA—lung cancer	4.79e-05	0.000405	CbGpPWpGaD
Metolazone—CA4—Metabolism—PTEN—lung cancer	4.69e-05	0.000396	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PIK3CA—lung cancer	4.48e-05	0.000378	CbGpPWpGaD
Metolazone—CA7—Metabolism—PIK3CA—lung cancer	4.48e-05	0.000378	CbGpPWpGaD
Metolazone—CA4—Metabolism—EP300—lung cancer	4.47e-05	0.000377	CbGpPWpGaD
Metolazone—CA9—Metabolism—PIK3CB—lung cancer	4.38e-05	0.00037	CbGpPWpGaD
Metolazone—CA9—Metabolism—PTGS2—lung cancer	4.34e-05	0.000367	CbGpPWpGaD
Metolazone—CA12—Metabolism—PIK3CA—lung cancer	4.15e-05	0.00035	CbGpPWpGaD
Metolazone—CA5A—Metabolism—AKT1—lung cancer	3.92e-05	0.000331	CbGpPWpGaD
Metolazone—CA9—Metabolism—PTEN—lung cancer	3.79e-05	0.00032	CbGpPWpGaD
Metolazone—CA5B—Metabolism—AKT1—lung cancer	3.66e-05	0.000309	CbGpPWpGaD
Metolazone—CA7—Metabolism—AKT1—lung cancer	3.66e-05	0.000309	CbGpPWpGaD
Metolazone—CA9—Metabolism—EP300—lung cancer	3.61e-05	0.000305	CbGpPWpGaD
Metolazone—CA12—Metabolism—AKT1—lung cancer	3.39e-05	0.000286	CbGpPWpGaD
Metolazone—CA4—Metabolism—PIK3CA—lung cancer	3.31e-05	0.000279	CbGpPWpGaD
Metolazone—CA4—Metabolism—AKT1—lung cancer	2.7e-05	0.000228	CbGpPWpGaD
Metolazone—CA9—Metabolism—PIK3CA—lung cancer	2.67e-05	0.000226	CbGpPWpGaD
Metolazone—CA9—Metabolism—AKT1—lung cancer	2.18e-05	0.000184	CbGpPWpGaD
